Kenneth Krogulski, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 7,107 shares at $1.29 ($9K) on 2024-10-02, disclosed to the SEC on 2024-11-05.
Scheduled purchase ($9k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.27 | 309 | $392 | 4.3% |
| 2 | $1.29 | 309 | $399 | 4.4% |
| 3 | $1.28 | 309 | $396 | 4.3% |
| 4 | $1.28 | 309 | $396 | 4.3% |
| 5 | $1.29 | 309 | $399 | 4.4% |
| 6 | $1.30 | 309 |
| $402 |
| 4.4% |
| 7 | $1.31 | 309 | $405 | 4.4% |
| 8 | $1.32 | 309 | $408 | 4.5% |
| 9 | $1.39 | 309 | $430 | 4.7% |
| 10 | $1.37 | 309 | $423 | 4.6% |
| 11 | $1.30 | 309 | $402 | 4.4% |
| 12 | $1.25 | 309 | $386 | 4.2% |
| 13 | $1.30 | 309 | $402 | 4.4% |
| 14 | $1.28 | 309 | $396 | 4.3% |
| 15 | $1.25 | 309 | $386 | 4.2% |
| 16 | $1.25 | 309 | $386 | 4.2% |
| 17 | $1.26 | 309 | $389 | 4.3% |
| 18 | $1.24 | 309 | $383 | 4.2% |
| 19 | $1.23 | 309 | $380 | 4.2% |
| 20 | $1.25 | 309 | $386 | 4.2% |
| 21 | $1.24 | 309 | $383 | 4.2% |
| 22 | $1.32 | 309 | $408 | 4.5% |
| 23 | $1.20 | 309 | $371 | 4.1% |
| Total | $1.28 avg | 7,107 | $9K | 100% |
| Filing → |
| CPIX | BUY | 2025-07-11 | $5K | — | Filing → |
| CPIX | BUY | 2025-06-06 | $5K | — | Filing → |
| CPIX | BUY | 2025-05-09 | $5K | — | Filing → |